JP2020528888A5 - - Google Patents

Download PDF

Info

Publication number
JP2020528888A5
JP2020528888A5 JP2020502672A JP2020502672A JP2020528888A5 JP 2020528888 A5 JP2020528888 A5 JP 2020528888A5 JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020528888 A5 JP2020528888 A5 JP 2020528888A5
Authority
JP
Japan
Prior art keywords
composition
iron
salt
iii
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020502672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020528888A (ja
Filing date
Publication date
Priority claimed from IT102017000085412A external-priority patent/IT201700085412A1/it
Application filed filed Critical
Publication of JP2020528888A publication Critical patent/JP2020528888A/ja
Publication of JP2020528888A5 publication Critical patent/JP2020528888A5/ja
Priority to JP2023076299A priority Critical patent/JP2023090869A/ja
Pending legal-status Critical Current

Links

JP2020502672A 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物 Pending JP2020528888A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076299A JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT102017000085412 2017-07-26
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076299A Division JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Publications (2)

Publication Number Publication Date
JP2020528888A JP2020528888A (ja) 2020-10-01
JP2020528888A5 true JP2020528888A5 (https=) 2021-09-02

Family

ID=60451085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020502672A Pending JP2020528888A (ja) 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Country Status (19)

Country Link
US (1) US20200206157A1 (https=)
EP (1) EP3657963A1 (https=)
JP (2) JP2020528888A (https=)
KR (1) KR20200032691A (https=)
CN (1) CN111031813A (https=)
BR (1) BR112020000902B1 (https=)
CA (1) CA3070659A1 (https=)
CL (1) CL2020000170A1 (https=)
CO (1) CO2020000526A2 (https=)
EA (1) EA202090069A1 (https=)
IL (1) IL272138B2 (https=)
IT (1) IT201700085412A1 (https=)
JO (1) JOP20200012A1 (https=)
MA (1) MA49794A (https=)
MX (1) MX2020000806A (https=)
PE (1) PE20200794A1 (https=)
PH (1) PH12020550031A1 (https=)
WO (1) WO2019021232A1 (https=)
ZA (1) ZA202000461B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237054A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
MX2020013302A (es) 2018-06-08 2021-05-12 Epizon Pharma Inc Métodos y composiciones para prevenir o tratar calcificación de tejido.
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
JP2025518284A (ja) 2022-05-31 2025-06-12 リージョン スイダンマーク 冠動脈石灰化(cac)の治療に使用するためのビタミンk2

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
WO1996039053A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
CN101094681A (zh) * 2003-10-28 2007-12-26 爱默蕾大学 透析液及其相关方法和系统
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
BRPI0620425B8 (pt) * 2005-12-23 2021-06-22 Gupta Ajay composição para nutrição parenteral, método para preparar a mesma, uso, e, kit
EP3066923B1 (en) * 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
CN102159222B (zh) * 2008-12-25 2014-08-06 I.B.E.有限会社 生物活性剂,药物,化妆品,保鲜剂,以及植物以及动物的发育促进剂
RU2606767C2 (ru) * 2011-05-20 2017-01-10 Фрисланд Брандз Б.В. Композиция, содержащая витамин k2
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
EP3258924A2 (en) * 2015-02-20 2017-12-27 VitaK B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Similar Documents

Publication Publication Date Title
JP2020528888A5 (https=)
JP2023090869A5 (https=)
JP5829607B2 (ja) ω3脂肪酸の配合製剤
JP2014077003A5 (https=)
US20100166918A1 (en) Nutraceuticals containing nitro fatty acids
JP2016510326A5 (https=)
JP2014530897A5 (https=)
JP2016517851A5 (https=)
RU2017114933A (ru) Соединения и композиции для лечения или профилактики патологических состояний, связанных с избыточным отложением фибрина и/или образованием тромбов
JP2016511753A5 (https=)
JP5788527B2 (ja) キナーゼ阻害剤の副作用低減剤
JP2014517001A5 (https=)
JP2019206562A5 (https=)
JP2017523219A5 (https=)
CN105339006A (zh) 含有脂肪酸和亚硝酸盐的营养或膳食补充剂
WO2018193648A1 (ja) アルカリ性化剤による血液浄化
US9968629B2 (en) Product and method for supporting uridine homeostasis
RU2019122735A (ru) Способы и композиции для предотвращения или минимизации эпителиально-мезенхимального перехода
JP2018507260A5 (https=)
PT1635838E (pt) Inibidores da fosfodiesterase 5 para a profilaxia e/ou terapia da hipertonia portal
JP2018521031A5 (https=)
JP2017515899A5 (https=)
JP2009515951A5 (https=)
CA3060154A1 (en) Blood purification by alkalinizing agent
KR20220098757A (ko) Bet 브로모도메인 억제제 및 나트륨 의존 글루코스 수송 2 억제제와 병용하여 주요 부정적 심혈관 사건 (mace)을 치료 및/또는 예방하는 방법